1. Home
  2. CDNA vs COUR Comparison

CDNA vs COUR Comparison

Compare CDNA & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • COUR
  • Stock Information
  • Founded
  • CDNA 1998
  • COUR 2012
  • Country
  • CDNA United States
  • COUR United States
  • Employees
  • CDNA N/A
  • COUR N/A
  • Industry
  • CDNA Medical Specialities
  • COUR Computer Software: Prepackaged Software
  • Sector
  • CDNA Health Care
  • COUR Technology
  • Exchange
  • CDNA Nasdaq
  • COUR Nasdaq
  • Market Cap
  • CDNA 1.1B
  • COUR 1.1B
  • IPO Year
  • CDNA 2014
  • COUR 2021
  • Fundamental
  • Price
  • CDNA $18.90
  • COUR $6.85
  • Analyst Decision
  • CDNA Buy
  • COUR Buy
  • Analyst Count
  • CDNA 8
  • COUR 14
  • Target Price
  • CDNA $29.43
  • COUR $10.41
  • AVG Volume (30 Days)
  • CDNA 661.3K
  • COUR 1.7M
  • Earning Date
  • CDNA 04-30-2025
  • COUR 04-24-2025
  • Dividend Yield
  • CDNA N/A
  • COUR N/A
  • EPS Growth
  • CDNA N/A
  • COUR N/A
  • EPS
  • CDNA 0.93
  • COUR N/A
  • Revenue
  • CDNA $333,785,000.00
  • COUR $694,674,000.00
  • Revenue This Year
  • CDNA $13.33
  • COUR $5.96
  • Revenue Next Year
  • CDNA $15.07
  • COUR $5.32
  • P/E Ratio
  • CDNA $20.32
  • COUR N/A
  • Revenue Growth
  • CDNA 19.07
  • COUR 9.27
  • 52 Week Low
  • CDNA $7.42
  • COUR $5.76
  • 52 Week High
  • CDNA $34.84
  • COUR $13.11
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 50.38
  • COUR 47.96
  • Support Level
  • CDNA $15.78
  • COUR $5.76
  • Resistance Level
  • CDNA $20.13
  • COUR $7.03
  • Average True Range (ATR)
  • CDNA 1.37
  • COUR 0.34
  • MACD
  • CDNA 0.24
  • COUR 0.05
  • Stochastic Oscillator
  • CDNA 71.72
  • COUR 67.81

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: